| 000 | 01756 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514181745.0 | ||
| 264 | 0 | _c20040402 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a0021-972X | ||
| 024 | 7 |
_a10.1210/jc.2003-031506 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrown, Todd T | |
| 245 | 0 | 0 |
_aReduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cMar 2004 |
||
| 300 |
_a1200-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdipose Tissue _xmetabolism |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xadverse effects |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Diseases, Metabolic _xepidemiology |
| 650 | 0 | 4 | _aBone Remodeling |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 | _aGlucose Tolerance Test |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xepidemiology |
| 650 | 0 | 4 |
_aHyperlipidemias _xepidemiology |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aRuppe, Mary D | |
| 700 | 1 | _aKassner, Rory | |
| 700 | 1 | _aKumar, Princy | |
| 700 | 1 | _aKehoe, Theresa | |
| 700 | 1 | _aDobs, Adrian S | |
| 700 | 1 | _aTimpone, Joseph | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 89 _gno. 3 _gp. 1200-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2003-031506 _zAvailable from publisher's website |
| 999 |
_c14721801 _d14721801 |
||